Package Devices, Inc. v. Sun Ray Drug Co.

301 F. Supp. 768, 162 U.S.P.Q. (BNA) 400, 1969 U.S. Dist. LEXIS 13145
District Court, E.D. Pennsylvania·Decided April 28, 1969·No. Civ. A. Nos. 30984, 34333, 34334, 34483·Published·Cited by 7 cases

Opinion

OPINION AND ORDER

FULLAM, District Judge.

This is a consolidated action for infringement of United States letters of patent number 2,620,938 (hereinafter ’938). Defendants seek a declaration of invalidity and non-infringement. Pursuant to Rule 42(b) of Fed.R.Civ.P., the issues of liability for infringement and damages have been separated. Upon review of the trial record, and consideration of the proposed findings of fact and conclusions of law, the Court makes the following:

FINDINGS OF FACT

1. The ’938 patent was originally issued to Mr. Charles Jesnig on December 9, 1952. Mr. Jesnig died before trial. Plaintiff Package Devices, Inc., (hereinafter PDI), is now the rightful owner of ’938.

[770]*7702. Plaintiff PDI is a Pennsylvania corporation having its principal office in Philadelphia, Pennsylvania.

3. Defendant, Sun Ray Drug Co. is a Pennsylvania corporation, having its principal place of business in Philadelphia, Pennsylvania.

4. Defendant, Owens-Illinois Glass Co. is an Ohio corporation, having a regular and established place of business at Philadelphia, Pennsylvania.

5. Defendant, Wyeth Laboratories Division, American Home Products Corp. is a Delaware corporation, having a regular and established place of business in Wynnewood, Pennsylvania.

6. Defendant, E. J. Korvette is a New York corporation, having a regular and established place of business at Philadelphia, Pennsylvania.

7. Owens-Illinois Glass Company (hereinafter Owens-Illinois) is a manufacturer of the accused structures, and Sun Ray Drug Co., Wyeth Laboratories, and E. J. Korvette, Inc. have marketed products in these structures.

8. The subject matter of the ’938 patent is the design of a container finish, particularly the neck ring, and the design of an elastomer container cap. Products such as aspirin are marketed in containers with the so-called snap-tops which are alleged to infringe ’938.

9. The inventor, Mr. Jesnig, conceived his invention in January of 1947, while engaged in research to develop method of vacuumizing tin can containers. He made a polyethylene cap to fit over a model with a 30°/30° conical finish on February 4, 1947.

10. At some time before May 12, 1948, Mr. Jesnig was requested by Mr. Nack, an employee of Sharpe & Dohme, Inc., to endeavor to develop a suitable closure for serum vials which the Wheaton Glass Co. was currently manufacturing and supplying to Sharpe & Dohme, Inc.

11. Subsequent to the meeting with Mr. Nack, but prior to May 12, 1948, Mr. Jesnig prepared a lucite model of a closure and a neck finish which reflected the concepts incorporated in the tin-can experiment of February 4, 1947, and which was essentially the same as the ’938 patent.

12. Mr. Wheaton, of the Wheaton Glass Co., (hereinafter Wheaton), found Jesnig’s model acceptable, but for expediency decided to use the closure with a standard rounded finish that was presently available.

13. After the meeting with Mr. Wheaton, Mr. Jesnig began the process of preparing a patent application concerning the use of his closure with the standard rounded finish which Mr. Wheaton had decided to use. The application was filed on May 12, 1948, and United States Letters of Patent No. 2,-587,327 (hereinafter ’327) was issued on February 26, 1952.

14. After his original decision to use a standard rounded finish, Wheaton developed a glass finish with a 30°/30° conical surface. This new finish was design to imitate the finish of the original model which Jesnig had shown to Mr. Wheaton, and production drawings were in existence on October 22, 1948. Production of bottles with the new finish was underway by February 1949.

15. On January 24, 1949, PDI, the assignee from Jesnig of patent application No. 26687 (this application matured into the ’327 patent) entered into a licensing agreement with Wheaton. The subject of this agreement was the closure or the snap-cap that was to be used with the standard rounded finish.

16. Bristol Myers, a vendee of Wheat-on, forwarded Wheaton’s production drawings of the 30°/30° conical neck ring to Owens-Illinois some time just prior to July 5, 1949. Owens-Illinois manufactured bottles in accord with the Wheaton drawing in December of 1949.

17. The prosecution of the ’938 patent was initiated on September 12, 1949, and the patent was issued on December 9, 1952. Ten claims were contained in the original application. Shortly thereafter, November 22, 1949, Claims 11 and [771]*77113 were added. These were designed to elucidate the importance of the neck ring and the interaction of the neck ring and cap. All thirteen claims were rejected by the Examiner on January 27, 1950, on the basis of prior art. The term “apex” was used in Claims 11 and 12 to describe the juncture of the outward and inward tapers of the container ring. No definition of appex was contained in these claims; however, the application described the apex as a “peak or line.”

18. In response to the Examiner’s action of January 27, 1950, amendments were made by a letter dated May 31, 1950. These amended Claims, 1 through 13, were again rejected on the basis of prior art.

19. By letter dated May 9, 1951, all thirteen claims were cancelled and Claims 14 through 18 were added. On July 3, 1951, Claims 19 through 25 were added and Claims 14 through 18 were cancelled without any action being taken by the Examiner. The term “apex” was again used to describe the juncture point. The Examiner rejected Claims 19 through 25 on July 31, 1951. His basis, again, was prior art.

20. On January 25, 1952, plaintiff cancelled his prior claims and added Claims 26 through 28. An affidavit by Dr. Mauehly accompanied these amendments. The language “steep annular apex” was used in. these claims. In the statement supporting these amendments, Mr. Jesnig described the neck ring as “two flats coming up to a steep apex or knife edge which acts as a fulcrum * * * ” (D.E. 71 p. 58) On February 21, 1952, Claims 26 and 28 were rejected on the basis of prior art, but 27 was allowed if the term “steep” was eliminated. The Examiner observed: “The word ‘steep’ in [the three claims] is objected to as being meaningless and indefinite as used in these claims.” (D.E. 71 p. 82)

21. On February 21, 1952, Mr. Jesnig, apparently unaware of the Examiner’s action of that date, cancelled all previous claims and substituted Claims 29 through 31. In these he used the language “annular peak line” to refer to the juncture of the inward and outward tapers. In the accompanying statement, Mr. Jesnig emphasized the importance of the design of the neck ring:

“The neck ring should make a rapid transition from one of these conical surfaces to the other and at an apex which is essentially a circular edge. * * * The object here is to minimize the possible position in which the cap could remain in a state of neutral equilibrium instead of either sealing properly or coming back off.” (D.E. 71 p. 89)

Free access — add to your briefcase to read the full text and ask questions with AI

Package Devices, Inc. v. Sun Ray Drug Co., 301 F. Supp. 768, 162 U.S.P.Q. (BNA) 400, 1969 U.S. Dist. LEXIS 13145 (E.D. Pa. 1969).

301 F. Supp. 768 (Package Devices, Inc. v. Sun Ray Drug Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related